Wednesday 23 December 2009

Bodrexin




Bodrexin may be available in the countries listed below.


Ingredient matches for Bodrexin



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Bodrexin in the following countries:


  • Indonesia

International Drug Name Search

Monday 14 December 2009

Onium




Onium may be available in the countries listed below.


Ingredient matches for Onium



Tiemonium Methylsulfate

Tiemonium Methylsulfate is reported as an ingredient of Onium in the following countries:


  • Bangladesh

International Drug Name Search

Friday 11 December 2009

Harmomed




Harmomed may be available in the countries listed below.


Ingredient matches for Harmomed



Diazepam

Diazepam is reported as an ingredient of Harmomed in the following countries:


  • Austria

Dosulepin

Dosulepin hydrochloride (a derivative of Dosulepin) is reported as an ingredient of Harmomed in the following countries:


  • Austria

International Drug Name Search

Tuesday 10 November 2009

Antagonil




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Antagonil



Yohimbine

Yohimbine hydrochloride (a derivative of Yohimbine) is reported as an ingredient of Antagonil in the following countries:


  • United States

International Drug Name Search

Tuesday 27 October 2009

Fordiab




Fordiab may be available in the countries listed below.


Ingredient matches for Fordiab



Gliquidone

Gliquidone is reported as an ingredient of Fordiab in the following countries:


  • Indonesia

International Drug Name Search

Friday 16 October 2009

Ancobon


Ancobon is a brand name of flucytosine, approved by the FDA in the following formulation(s):


ANCOBON (flucytosine - capsule; oral)



  • Manufacturer: VALEANT

    Approved Prior to Jan 1, 1982

    Strength(s): 250MG [AB], 500MG [RLD][AB]

Has a generic version of Ancobon been approved?


Yes. The following products are equivalent to Ancobon:


flucytosine capsule; oral



  • Manufacturer: SIGMAPHARM LABS LLC

    Approval date: June 28, 2011

    Strength(s): 250MG [AB], 500MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ancobon. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Ancobon.

See also...

  • Ancobon Consumer Information (Wolters Kluwer)
  • Ancobon Consumer Information (Cerner Multum)
  • Ancobon Advanced Consumer Information (Micromedex)
  • Ancobon AHFS DI Monographs (ASHP)
  • Flucytosine Consumer Information (Wolters Kluwer)
  • Flucytosine Consumer Information (Cerner Multum)
  • Flucytosine Advanced Consumer Information (Micromedex)
  • Flucytosine AHFS DI Monographs (ASHP)

Monday 12 October 2009

Citaxin




Citaxin may be available in the countries listed below.


Ingredient matches for Citaxin



Citalopram

Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Citaxin in the following countries:


  • Poland

International Drug Name Search

Friday 9 October 2009

Beta-Carotene


Pronunciation: BAY-tah KARE-oh-teen
Generic Name: Beta-Carotene
Brand Name: Generic only. No brands available.


Beta-Carotene is used for:

Treating vitamin A deficiency. It may also be used for other conditions as determined by your doctor.


Beta-Carotene is a precursor to vitamin A, a fat-soluble vitamin.


Do NOT use Beta-Carotene if:


  • you are allergic to any ingredient in Beta-Carotene

  • you are taking vitamin A supplements or any multivitamins that contain vitamin A

  • you are taking acitretin

Contact your doctor or health care provider right away if any of these apply to you.



Before using Beta-Carotene:


Some medical conditions may interact with Beta-Carotene. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you take large doses of vitamins (megadoses or multivitamin therapy)

Some MEDICINES MAY INTERACT with Beta-Carotene. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Acitretin because the risk of serious side effects may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Beta-Carotene may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Beta-Carotene:


Use Beta-Carotene as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Beta-Carotene with food or milk.

  • Take Beta-Carotene regularly to receive the most benefit from it. Taking Beta-Carotene at the same time each day will help you remember to take it.

  • If you miss a dose of Beta-Carotene, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Beta-Carotene.



Important safety information:


  • Beta-Carotene may cause increased sensitivity to the sun. Avoid exposure to the sun, sunlamps, or tanning booths until you know how you react to Beta-Carotene. Use a sunscreen or protective clothing if you must be outside for a prolonged period.

  • Your skin may turn slightly yellow while you are taking Beta-Carotene. This is harmless and not a cause for concern.

  • Do not take large doses of vitamins (megadoses or megavitamin therapy) while taking Beta-Carotene unless directed by your doctor.

  • PREGNANCY and BREAST-FEEDING: If you plan on becoming pregnant, discuss with your doctor the benefits and risks of using Beta-Carotene during pregnancy. If you are or will be breast feeding while you are using Beta-Carotene, check with your doctor or pharmacist to discuss the risks to your baby.


Possible side effects of Beta-Carotene:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Diarrhea.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Beta-Carotene side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Beta-Carotene:

Store Beta-Carotene at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Beta-Carotene out of the reach of children and away from pets.


General information:


  • If you have any questions about Beta-Carotene, please talk with your doctor, pharmacist, or other health care provider.

  • Beta-Carotene is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Beta-Carotene. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Beta-Carotene resources


  • Beta-Carotene Side Effects (in more detail)
  • Beta-Carotene Use in Pregnancy & Breastfeeding
  • Beta-Carotene Drug Interactions
  • Beta-Carotene Support Group
  • 0 Reviews for Beta-Carotene - Add your own review/rating


Compare Beta-Carotene with other medications


  • Vitamin A Deficiency

Saturday 26 September 2009

Strumazol




Strumazol may be available in the countries listed below.


Ingredient matches for Strumazol



Thiamazole

Thiamazole is reported as an ingredient of Strumazol in the following countries:


  • Belgium

  • Luxembourg

  • Netherlands

  • Philippines

International Drug Name Search

Friday 18 September 2009

Duricef


Pronunciation: SEFF-ah-DROX-il
Generic Name: Cefadroxil
Brand Name: Duricef


Duricef is used for:

Treating infections caused by certain bacteria.


Duricef is a cephalosporin antibiotic. It works by interfering with the bacteria's cell wall formation. This weakens the cell wall, causing it to rupture, resulting in death of the bacteria.


Do NOT use Duricef if:


  • you are allergic to any ingredient in Duricef or any other cephalosporin (eg, cephalexin)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Duricef:


Some medical conditions may interact with Duricef. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a blood clotting disorder, kidney problems, or stomach or bowel problems (eg, inflammation)

  • if you have had a severe allergic reaction (eg, a severe rash, hives, breathing difficulties, or dizziness) to a penicillin antibiotic (eg, amoxicillin) or other beta-lactam antibiotic (eg, imipenem)

Some MEDICINES MAY INTERACT with Duricef. However, no specific interactions with Duricef are known at this time.


Ask your health care provider if Duricef may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Duricef:


Use Duricef as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Duricef by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.

  • To clear up your infection completely, take Duricef for the full course of treatment. Keep taking it even if you feel better in a few days.

  • If you miss a dose of Duricef, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Duricef.



Important safety information:


  • Contact your doctor right away if stomach pain or cramps, severe diarrhea, or bloody stools occur. Do not treat diarrhea without first checking with your doctor.

  • Be sure to use Duricef for the full course of treatment. If you do not, the medicine may not clear up your infection completely. The bacteria could also become less sensitive to this or other medicines. This could make the infection harder to treat in the future.

  • Duricef only works against bacteria; it does not treat viral infections (eg, the common cold).

  • Long-term or repeated use of Duricef may cause a second infection. Tell your doctor if signs of a second infection occur. Your medicine may need to be changed to treat this.

  • Diabetes patients - Duricef may cause the results of some tests for urine glucose to be wrong. Ask your doctor before you change your diet or the dose of your diabetes medicine.

  • Duricef may interfere with certain lab tests. Be sure your doctor and lab personnel know you are taking Duricef.

  • Use Duricef with caution in the ELDERLY; they may be more sensitive to the effects of Duricef.

  • Use Duricef with extreme caution in CHILDREN younger than 10 years old who have diarrhea or an infection of the stomach or bowel.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Duricef while you are pregnant. Duricef is found in breast milk. If you are or will be breast-feeding while you use Duricef, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Duricef:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Diarrhea; nausea; stomach upset; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bloody diarrhea; dark urine; decreased urination; fever, chills, or sore throat; joint pain; red, swollen, or blistered skin; seizures; severe diarrhea; stomach pain or cramps; unusual bruising or bleeding; unusual tiredness or weakness; vaginal itching, odor, or discharge; yellowing of the skin or eyes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Duricef side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include muscle spasms; seizures.


Proper storage of Duricef:

Store Duricef at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Duricef out of the reach of children and away from pets.


General information:


  • If you have any questions about Duricef, please talk with your doctor, pharmacist, or other health care provider.

  • Duricef is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Duricef. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Duricef resources


  • Duricef Side Effects (in more detail)
  • Duricef Dosage
  • Duricef Use in Pregnancy & Breastfeeding
  • Drug Images
  • Duricef Drug Interactions
  • Duricef Support Group
  • 0 Reviews for Duricef - Add your own review/rating


  • Duricef Prescribing Information (FDA)

  • Duricef Advanced Consumer (Micromedex) - Includes Dosage Information

  • Duricef Concise Consumer Information (Cerner Multum)

  • Duricef Monograph (AHFS DI)

  • Cefadroxil Prescribing Information (FDA)

  • Cefadroxil Professional Patient Advice (Wolters Kluwer)



Compare Duricef with other medications


  • Bacterial Endocarditis Prevention
  • Impetigo
  • Kidney Infections
  • Skin and Structure Infection
  • Skin Infection
  • Tonsillitis/Pharyngitis
  • Upper Respiratory Tract Infection
  • Urinary Tract Infection

Thursday 17 September 2009

Lamotrigina Arrowblue




Lamotrigina Arrowblue may be available in the countries listed below.


Ingredient matches for Lamotrigina Arrowblue



Lamotrigine

Lamotrigine is reported as an ingredient of Lamotrigina Arrowblue in the following countries:


  • Portugal

International Drug Name Search

Saturday 12 September 2009

Tranquirit




Tranquirit may be available in the countries listed below.


Ingredient matches for Tranquirit



Diazepam

Diazepam is reported as an ingredient of Tranquirit in the following countries:


  • Italy

International Drug Name Search

Tuesday 8 September 2009

Braunoderm




Braunoderm may be available in the countries listed below.


Ingredient matches for Braunoderm



Isopropyl Alcohol

Isopropyl Alcohol is reported as an ingredient of Braunoderm in the following countries:


  • Belgium

  • Germany

  • Ireland

  • Luxembourg

  • Poland

  • Slovenia

  • Switzerland

Povidone Iodine

Povidone-Iodine is reported as an ingredient of Braunoderm in the following countries:


  • Belgium

  • Germany

  • Ireland

  • Luxembourg

  • Poland

  • Slovenia

  • Switzerland

International Drug Name Search

Monday 7 September 2009

D Vital




D Vital may be available in the countries listed below.


Ingredient matches for D Vital



Calcium Carbonate

Calcium Carbonate is reported as an ingredient of D Vital in the following countries:


  • Belgium

Colecalciferol

Colecalciferol is reported as an ingredient of D Vital in the following countries:


  • Belgium

International Drug Name Search

Sunday 6 September 2009

Apo-Desipramine




Apo-Desipramine may be available in the countries listed below.


Ingredient matches for Apo-Desipramine



Desipramine

Desipramine hydrochloride (a derivative of Desipramine) is reported as an ingredient of Apo-Desipramine in the following countries:


  • Canada

International Drug Name Search

Saturday 5 September 2009

Sertralina Pharmagenus




Sertralina Pharmagenus may be available in the countries listed below.


Ingredient matches for Sertralina Pharmagenus



Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertralina Pharmagenus in the following countries:


  • Spain

International Drug Name Search

Tuesday 18 August 2009

Cotrisan




Cotrisan may be available in the countries listed below.


Ingredient matches for Cotrisan



Clotrimazole

Clotrimazole is reported as an ingredient of Cotrisan in the following countries:


  • Chile

International Drug Name Search

Saturday 15 August 2009

Almagel




Almagel may be available in the countries listed below.


Ingredient matches for Almagel



Aluminium Hydroxide

Aluminium Hydroxide hydrate (Algeldrate) (a derivative of Aluminium Hydroxide) is reported as an ingredient of Almagel in the following countries:


  • Russian Federation

Magnesium Hydroxide

Magnesium Hydroxide is reported as an ingredient of Almagel in the following countries:


  • Russian Federation

International Drug Name Search

Wednesday 12 August 2009

Peledox




Peledox may be available in the countries listed below.


Ingredient matches for Peledox



Doxycycline

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Peledox in the following countries:


  • Spain

International Drug Name Search

Monday 10 August 2009

Clinax




Clinax may be available in the countries listed below.


Ingredient matches for Clinax



Minocycline

Minocycline is reported as an ingredient of Clinax in the following countries:


  • Argentina

Sulindac

Sulindac is reported as an ingredient of Clinax in the following countries:


  • Japan

International Drug Name Search

Sunday 9 August 2009

Buten




Buten may be available in the countries listed below.


Ingredient matches for Buten



Ambroxol

Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Buten in the following countries:


  • Dominican Republic

International Drug Name Search

Saturday 8 August 2009

Loratadina Rimafar




Loratadina Rimafar may be available in the countries listed below.


Ingredient matches for Loratadina Rimafar



Loratadine

Loratadine is reported as an ingredient of Loratadina Rimafar in the following countries:


  • Spain

International Drug Name Search

Friday 7 August 2009

Oximinth




Oximinth may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Oximinth



Dichlorvos

Dichlorvos is reported as an ingredient of Oximinth in the following countries:


  • Australia

Oxibendazole

Oxibendazole is reported as an ingredient of Oximinth in the following countries:


  • Australia

International Drug Name Search

Monday 27 July 2009

Conducil




Conducil may be available in the countries listed below.


Ingredient matches for Conducil



Nifedipine

Nifedipine is reported as an ingredient of Conducil in the following countries:


  • Venezuela

International Drug Name Search

Wednesday 22 July 2009

Bicnu


Generic Name: carmustine (Intravenous route)

kar-MUS-teen

Intravenous route(Powder for Solution)

Bone marrow suppression, notably thrombocytopenia and leukopenia, which may contribute to bleeding and overwhelming infections in an already compromised patient, is the most common and severe of the toxic effects of carmustine. Blood counts should be monitored weekly for at least 6 weeks after a dose. At the recommended dosage, courses of carmustine should not be given more frequently than every 6 weeks. Pulmonary toxicity from carmustine appears to be dose related, as patients receiving greater than 1400 mg/m(2) cumulative dose are at significantly higher risk than those receiving less. Delayed pulmonary toxicity can occur years after treatment, and can result in death, particularly in patients treated in childhood .



Commonly used brand name(s)

In the U.S.


  • Bicnu

Available Dosage Forms:


  • Powder for Solution

Therapeutic Class: Antineoplastic Agent


Pharmacologic Class: Alkylating Agent


Chemical Class: Nitrosourea


Uses For Bicnu


Carmustine injection is used alone or together with other medicines to treat certain type of brain tumors (e.g., glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma, and metastatic brain tumors), cancer of the lymph system (e.g., Hodgkin's disease, non-Hodgkin's lymphoma), and a certain type of cancer in the bone marrow (e.g., multiple myeloma). It may also be used to treat other kinds of cancer, as determined by your doctor.


Carmustine belongs to the group of alkylating agents. It interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by carmustine, other effects may occur. Some of these may be serious and must be reported to your doctor. Other effects (e.g., hair loss), may not be serious but may cause concern. Some effects may not occur for months or years after the medicine is used.


Before you begin treatment with carmustine, you and your doctor should talk about the benefits this medicine will do as well as the risks.


This medicine is to be administered only by or under the immediate supervision of your doctor.


Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, carmustine injection is used in certain patients with the following conditions:


  • Cancer of the colon and rectum.

  • Cancer of the stomach.

  • Malignant melanoma (a type of skin cancer).

  • Mycosis fungoides (tumors on the skin).

  • Waldenström's macroglobulinemia (a certain type of cancer of the blood).

Before Using Bicnu


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies on the relationship of age to the effects of carmustine injection have not been performed in the pediatric population. Safety and efficacy have not been established.


Geriatric


No information is available on the relationship of age to the effects of carmustine injection in geriatric patients. However, elderly patients are more likely to have age-related kidney, liver, or heart problems, which may require caution and an adjustment in the dose for patients receiving carmustine injection.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersDStudies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy in a life threatening situation or a serious disease, may outweigh the potential risk.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Rotavirus Vaccine, Live

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Adenovirus Vaccine Type 4, Live

  • Adenovirus Vaccine Type 7, Live

  • Bacillus of Calmette and Guerin Vaccine, Live

  • Cimetidine

  • Influenza Virus Vaccine, Live

  • Measles Virus Vaccine, Live

  • Mumps Virus Vaccine, Live

  • Rotavirus Vaccine, Live

  • Rubella Virus Vaccine, Live

  • Smallpox Vaccine

  • Typhoid Vaccine

  • Varicella Virus Vaccine

  • Yellow Fever Vaccine

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Anemia (low red cells in the blood) or

  • Bone marrow problems (e.g., leukemia) or

  • Leukopenia or neutropenia (low white cells in the blood) or

  • Liver disease or

  • Thrombocytopenia (low platelets in the blood)—Use with caution. May make these conditions worse.

  • Chickenpox (including recent exposure) or

  • Herpes zoster (shingles) or

  • Infection—May decrease the body's ability to fight an infection.

  • Kidney disease—Use with caution. The effects may be increased because of slower removal of the medicine from the body.

  • Lung disease (e.g., pulmonary fibrosis, pulmonary toxicity)—Use with caution. May increase risk of lung problems.

Proper Use of Bicnu


Medicines used to treat cancer are very strong and can have many side effects. Before receiving this medicine, make sure you understand all the risks and benefits. It is important for you to work closely with your doctor during your treatment.


A nurse or other trained health professional will give you this medicine in a hospital. This medicine is given through a needle placed in one of your veins.


This medicine is usually given every 6 weeks. This maybe given as a single dose or divided into daily injections on two consecutive days.


Carmustine is sometimes given together with certain other medicines. If you are using a combination of medicines, it is important that you receive each one at the proper time. If you are taking some of these medicines by mouth, ask your doctor to help you plan a way to take them at the right times.


This medicine often causes nausea and vomiting, which usually last no longer than 4 to 6 hours. It is very important that you continue to receive the medicine, even if you begin to feel ill. Ask your doctor for ways to lessen these effects.


Precautions While Using Bicnu


It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly. Blood and urine tests may be needed to check for unwanted effects.


Using this medicine while you are pregnant can harm your unborn baby. Use an effective form of birth control to keep from getting pregnant. If you think you have become pregnant while using the medicine, tell your doctor right away.


This medicine may increase your risk of developing cancer and lung problems (such as pulmonary fibrosis or toxicity). This is more likely if you receive high doses of this medicine or use it for a long time.


While you are being treated with carmustine injection, and after you stop treatment with it, do not have any immunizations (vaccines) without your doctor's approval. Carmustine may lower your body's resistance and the vaccine may not work as well for you or you might get the infection the vaccine is meant to prevent. In addition, you should not be around other persons living in your household who receive live vaccines because there is a chance they could pass the virus on to you. Some examples of live vaccines include measles, mumps, influenza (nasal flu vaccine), poliovirus (oral form), rotavirus, and rubella. Do not get close to them and do not stay in the same room with them for very long. If you have questions about this, talk to your doctor.


Carmustine can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of platelets, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take, especially when your blood count is low, to reduce the risk of infection or bleeding:


  • If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.

  • Check with your doctor immediately if you notice any unusual bleeding or bruising; black, tarry stools; blood in the urine or stools; or pinpoint red spots on your skin.

  • Be careful when using a regular toothbrush, dental floss, or toothpick. Your medical doctor, dentist, or nurse may recommend other ways to clean your teeth and gums. Check with your medical doctor before having any dental work done.

  • Do not touch your eyes or the inside of your nose unless you have just washed your hands and have not touched anything else in the meantime.

  • Be careful not to cut yourself when you are using sharp objects such as a safety razor or fingernail or toenail cutters.

  • Avoid contact sports or other situations where bruising or injury could occur.

If carmustine accidentally seeps out of the vein into which it is injected, it may damage some tissues and cause scarring. Tell the doctor or nurse right away if you notice redness, pain, or swelling at the injection site.


This medicine may increase risk of lung problems while smoking.


Bicnu Side Effects


Along with its needed effects, medicines like carmustine can sometimes cause some unwanted effects such as blood problems, loss of hair, and other side effects ; these are described below. Also, because of the way these medicines act on the body, there is a chance that they might cause other unwanted effects that may not occur until months or years after the medicine is used. These delayed effects may include certain types of cancer, such as leukemia. Discuss these possible effects with your doctor.


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor or nurse immediately if any of the following side effects occur:


More common
  • Cough

  • pain or redness at the injection site

  • shortness of breath

Less common
  • Black, tarry stools

  • blood in the urine or stools

  • cough or hoarseness, accompanied by fever or chills

  • fever or chills

  • flushing of the face

  • lower back or side pain, accompanied by fever or chills

  • painful or difficult urination, accompanied by fever or chills

  • pinpoint red spots on the skin

  • sores in the mouth or on the lips

  • unusual bleeding or bruising

  • unusual tiredness or weakness

Rare
  • Decrease in urination

  • swelling of the feet or lower legs

Incidence not known
  • Abdominal or stomach pain, severe

  • bleeding gums

  • bone pain

  • chest pain

  • cloudy urine

  • confusion

  • dark urine

  • decreased frequency or amount of urine

  • difficulty with swallowing

  • dizziness

  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position

  • dry mouth

  • fast, pounding, or irregular heartbeat or pulse

  • feeling of warmth

  • hives

  • increased blood pressure

  • increased thirst

  • itching

  • loss of appetite

  • nausea or vomiting

  • pain in the lower back or side

  • pale skin

  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue

  • redness of the face, neck, arms, and occasionally, upper chest

  • skin rash

  • sore throat

  • sweating

  • swelling of the face, fingers, or lower legs

  • swollen glands

  • thirst

  • tightness in the chest

  • troubled breathing

  • troubled breathing with exertion

  • weight gain

  • wheezing

  • yellow eyes or skin

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common
  • Diarrhea

  • discoloration of the skin along the injection site

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Bicnu side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Bicnu resources


  • Bicnu Side Effects (in more detail)
  • Bicnu Use in Pregnancy & Breastfeeding
  • Bicnu Drug Interactions
  • Bicnu Support Group
  • 0 Reviews for Bicnu - Add your own review/rating


  • Carmustine Professional Patient Advice (Wolters Kluwer)

  • Carmustine Monograph (AHFS DI)

  • BiCNU Prescribing Information (FDA)

  • BiCNU Concise Consumer Information (Cerner Multum)

  • BiCNU MedFacts Consumer Leaflet (Wolters Kluwer)

  • Gliadel Prescribing Information (FDA)

  • Gliadel Implant Wafer MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Bicnu with other medications


  • Brain Tumor
  • Glioblastoma Multiforme
  • Hodgkin's Lymphoma
  • Malignant Glioma
  • Multiple Myeloma
  • Non-Hodgkin's Lymphoma

Thursday 16 July 2009

Ranitidina Combix




Ranitidina Combix may be available in the countries listed below.


Ingredient matches for Ranitidina Combix



Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranitidina Combix in the following countries:


  • Spain

International Drug Name Search

Sunday 12 July 2009

Diclofenacnatrium FLX




Diclofenacnatrium FLX may be available in the countries listed below.


Ingredient matches for Diclofenacnatrium FLX



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclofenacnatrium FLX in the following countries:


  • Netherlands

International Drug Name Search

Friday 3 July 2009

Phorpain




Phorpain may be available in the countries listed below.


Ingredient matches for Phorpain



Ibuprofen

Ibuprofen is reported as an ingredient of Phorpain in the following countries:


  • Ireland

International Drug Name Search

Wednesday 1 July 2009

Promestriene




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

G03CA09

CAS registry number (Chemical Abstracts Service)

0039219-28-8

Chemical Formula

C22-H32-O2

Molecular Weight

328

Therapeutic Category

Estrogen

Chemical Name

Estra-1,3,5(10)-triene, 17-methoxy-3-propoxy-, (17ß)-

Foreign Names

  • Promestrienum (Latin)
  • Promestrien (German)
  • Promestriène (French)
  • Promestrieno (Spanish)

Generic Names

  • Promestriene (OS: DCIT)
  • Promestriène (OS: DCF)

Brand Names

  • Colposeptine (Promestriene and Chlorquinaldol)
    Théramex, Monaco


  • Colpotrofin
    Merck, Spain


  • Colpotrofine
    Altana, Brazil


  • Colpotrophine
    Merck, Argentina; Merck, Hong Kong; Merck, Peru; Merck, Turkey; Merck KGaA, China; Merck Theramex, Singapore; OM, Portugal; Theramex, China; Theramex, Latvia; Theramex, Malta; Theramex, Tunisia; Théramex, Burkina Faso; Théramex, Congo; Théramex, Cote D'ivoire; Théramex, Cameroon; Théramex, France; Théramex, Gabon; Théramex, Guinea; Théramex, Monaco; Théramex, Mali; Théramex, Mauritania; Théramex, Mauritius; Théramex, Romania; Théramex, Senegal; Théramex, Togo; Vifor, Switzerland


  • Delipoderm
    Reig Jofre, Spain

International Drug Name Search

Glossary

DCFDénomination Commune Française
DCITDenominazione Comune Italiana
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday 30 June 2009

Vironida LCH




Vironida LCH may be available in the countries listed below.


Ingredient matches for Vironida LCH



Acyclovir

Aciclovir is reported as an ingredient of Vironida LCH in the following countries:


  • Peru

International Drug Name Search

Wednesday 24 June 2009

Azlaire




Azlaire may be available in the countries listed below.


Ingredient matches for Azlaire



Pranlukast

Pranlukast is reported as an ingredient of Azlaire in the following countries:


  • Ecuador

  • Mexico

  • Peru

Pranlukast hemihydrate (a derivative of Pranlukast) is reported as an ingredient of Azlaire in the following countries:


  • Colombia

  • Costa Rica

  • Dominican Republic

  • El Salvador

  • Guatemala

  • Honduras

  • Mexico

  • Nicaragua

  • Panama

  • Venezuela

International Drug Name Search

Thursday 18 June 2009

Traumus




Traumus may be available in the countries listed below.


Ingredient matches for Traumus



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Traumus in the following countries:


  • Chile

International Drug Name Search

Sunday 14 June 2009

Spasmin




Spasmin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Spasmin



Metamizole

Metamizole sodium anhydrous (a derivative of Metamizole) is reported as an ingredient of Spasmin in the following countries:


  • Switzerland

Scopolamine

Scopolamine is reported as an ingredient of Spasmin in the following countries:


  • Bangladesh

International Drug Name Search

Derma-Smoothe/FS


Generic Name: fluocinolone (Topical application route)


floo-oh-SIN-oh-lone a-SEET-oh-nide


Commonly used brand name(s)

In the U.S.


  • Capex

  • Derma-Smoothe/FS

  • Synalar

In Canada


  • Fluoderm Mild Cream

  • Fluoderm Mild Ointment

  • Fluoderm Regular Cream

  • Fluoderm Regular Ointment

  • Fluolar Mild

  • Fluolar Regular

  • Fluonide Mild-Cream

  • Synalar Mild

  • Synalar Regular

  • Synamol

Available Dosage Forms:


  • Cream

  • Solution

  • Shampoo

  • Oil

  • Ointment

  • Lotion

  • Gel/Jelly

  • Kit

Therapeutic Class: Corticosteroid, Intermediate


Pharmacologic Class: Fluocinolone


Uses For Derma-Smoothe/FS


Fluocinolone topical is used to relieve redness, itching, swelling, or other discomfort caused by skin conditions. Fluocinolone scalp oil is used to treat psoriasis of the scalp, and fluocinolone shampoo for seborrheic dermatitis of the scalp. This medicine is a corticosteroid (cortisone-like medicine or steroid).


This medicine is available only with your doctor's prescription.


Before Using Derma-Smoothe/FS


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of fluocinolone topical in the pediatric population. However, because of this medicine's toxicity, it should be used with caution. Children may absorb large amounts through the skin, which can cause serious side effects. If your child is using this medicine, follow your doctor's instructions very carefully. For the body oil form, safety and efficacy in children 3 months of age and younger have not been established.


Geriatric


No information is available on the relationship of age to the effects of fluocinolone topical in geriatric patients.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Cushing's syndrome (adrenal gland disorder) or

  • Diabetes or

  • Hyperglycemia (high blood sugar) or

  • Intracranial hypertension (increased pressure in the head)—Use with caution. May make these conditions worse.

  • Infection of the skin at or near the place of application or

  • Large sores, broken skin, or severe skin injury at the place of application—The chance of side effects may be increased.

Proper Use of fluocinolone

This section provides information on the proper use of a number of products that contain fluocinolone. It may not be specific to Derma-Smoothe/FS. Please read with care.


It is very important that you use this medicine only as directed by your doctor. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered. To do so may cause unwanted side effects or skin irritation.


This medicine is for use on the skin only. Do not get it in your eyes. Do not use it on skin areas that have cuts, scrapes, or burns. If it does get on these areas, rinse it off right away with water.


This medicine should only be used for skin conditions that your doctor is treating. Check with your doctor before using it for other conditions, especially if you think that a skin infection may be present. This medicine should not be used to treat certain kinds of skin infections or conditions, such as severe burns.


To use cream, ointment, solution, and body oil:


  • Wash your hands with soap and water before and after using this medicine.

  • Apply a thin layer of this medicine to the affected area of the skin or scalp. Rub it in gently.

  • Do not bandage or otherwise wrap the skin being treated unless directed to do so by your doctor.

  • If the medicine is applied to the diaper area of an infant, do not use tight-fitting diapers or plastic pants unless directed to do so by your doctor.

  • If your doctor ordered an occlusive dressing or airtight covering to be applied over the medicine, make sure you know how to apply it. Occlusive dressings increase the amount of medicine absorbed through your skin, so use them only as directed. If you have any questions about this, check with your doctor.

To use shampoo:


  • Wash your hands with soap and water before and after using this medicine.

  • Wet hair and scalp thoroughly.

  • Shake the container well, and apply about an ounce of the shampoo to the scalp area.

  • Work the shampoo into a lather, and leave on the scalp for 5 minutes.

  • Wash hair and scalp thoroughly with water.

To use scalp oil:


  • Wash your hands with soap and water before and after using this medicine.

  • Wet hair and scalp thoroughly.

  • Apply a thin layer of this medicine to the affected area of the scalp. Rub it in gently.

  • Cover the scalp with the supplied shower cap overnight for at least 4 hours.

  • Wash hair with regular shampoo and clean well.

Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For redness, itching, and swelling of the skin:
    • For topical dosage form (cream, ointment, and solution):
      • Adults—Apply to the affected areas of the skin three to four times a day.

      • Children—Use and dose must be determined by your doctor.


    • For topical dosage form (body oil):
      • Adults—Apply to the affected areas of the skin three times a day for up to 2 weeks.

      • Children 3 months of age and older—Apply to the affected areas two times a day for up to 4 weeks.



  • For seborrheic dermatitis:
    • For topical dosage form (shampoo):
      • Adults—Use on the scalp area once a day.

      • Children—Use and dose must be determined by your doctor.



  • For scalp psoriasis:
    • For topical dosage form (scalp oil):
      • Adults—Apply to the affected areas of the scalp and leave overnight.

      • Children 2 years of age and older—Apply to the affected areas 2 times a day for up to 4 weeks.



Missed Dose


If you miss a dose of this medicine, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using Derma-Smoothe/FS


It is very important that your doctor check the progress of you or your child at regular visits for any unwanted effects that may be caused by this medicine.


If your or your child's symptoms do not improve within a few days, or if they become worse, check with your doctor.


Using too much of this medicine or using it for a long time may increase your risk of having adrenal gland problems. The risk is greater for children and patients who use large amounts for a long time. Talk to your doctor right away if you or your child have more than one of these symptoms while you are using this medicine: blurred vision; dizziness or fainting; a fast, irregular, or pounding heartbeat; increased thirst or urination; irritability; or unusual tiredness or weakness.


Stop using this medicine and check with your doctor right away if you or your child have a skin rash, burning, stinging, swelling, or irritation on the skin.


Derma-Smoothe/FS Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Body aches or pain

  • congestion

  • cough

  • dryness or soreness of the throat

  • fever

  • headache

  • hoarseness

  • lightening of normal skin color

  • lightening of treated areas of dark skin

  • sore throat

  • stuffy or runny nose

  • tender, swollen glands in the neck

  • trouble swallowing

  • unusual tiredness or weakness

  • voice changes

Less common
  • Acne or pimples

  • accumulation of pus

  • blistering, crusting, irritation, itching, or reddening of the skin

  • burning, itching, and pain in hairy areas, or pus at the root of the hair

  • burning and itching of the skin with pinhead-sized red blisters

  • change in hearing

  • cracked, dry, scaly skin

  • diarrhea

  • dry skin

  • earache or pain in the ear

  • ear drainage

  • flushing or redness of the skin

  • darkening of the skin

  • itching, scaling, severe redness, soreness, or swelling of the skin

  • itchy, raised, round, smooth, skin-colored bumps found on just one area of the body

  • ooze thick white fluid

  • raised, dark red, wart-like spots on skin, especially when used on the face

  • redness or swelling in the ear

  • skin irritation

  • skin rash, encrusted, scaly and oozing

  • spots on your skin resembling a blister or pimple

  • swelling

  • swollen, red, tender area of infection

  • thickened patches of the skin

  • vomiting

Incidence not known
  • Redness and scaling around the mouth

  • thinning, weakness, or wasting away of the skin

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common
  • Changes in skin color

  • shiny skin

Incidence not known
  • increased hair growth on the forehead, back, arms, and legs

  • reddish purple lines on the arms, face, legs, trunk, or groin

  • softening of the skin

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Derma-Smoothe/FS side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Derma-Smoothe/FS resources


  • Derma-Smoothe/FS Side Effects (in more detail)
  • Derma-Smoothe/FS Use in Pregnancy & Breastfeeding
  • Derma-Smoothe/FS Drug Interactions
  • Derma-Smoothe/FS Support Group
  • 0 Reviews for Derma-Smoothe/FS - Add your own review/rating


  • Capex Shampoo MedFacts Consumer Leaflet (Wolters Kluwer)

  • DermOtic Drops MedFacts Consumer Leaflet (Wolters Kluwer)

  • Synalar Prescribing Information (FDA)

  • Synalar Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Synalar Consumer Overview



Compare Derma-Smoothe/FS with other medications


  • Atopic Dermatitis
  • Dermatitis
  • Lichen Sclerosus

Wednesday 10 June 2009

Sucralan




Sucralan may be available in the countries listed below.


Ingredient matches for Sucralan



Sucralfate

Sucralfate is reported as an ingredient of Sucralan in the following countries:


  • Austria

  • Czech Republic

  • Romania

International Drug Name Search

Sunday 7 June 2009

Levoxal




Levoxal may be available in the countries listed below.


Ingredient matches for Levoxal



Levofloxacin

Levofloxacin is reported as an ingredient of Levoxal in the following countries:


  • Indonesia

Levofloxacin hemihydrate (a derivative of Levofloxacin) is reported as an ingredient of Levoxal in the following countries:


  • Indonesia

International Drug Name Search

Tuesday 2 June 2009

Sebolox




Sebolox may be available in the countries listed below.


Ingredient matches for Sebolox



Miconazole

Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Sebolox in the following countries:


  • Switzerland

International Drug Name Search

Friday 22 May 2009

Bromisoval




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05CM03

CAS registry number (Chemical Abstracts Service)

0000496-67-3

Chemical Formula

C6-H11-Br-N2-O2

Molecular Weight

223

Therapeutic Category

Hypnotic and sedative agent

Chemical Name

Butanamide, N-(aminocarbonyl)-2-bromo-3-methyl-

Foreign Names

  • Bromisovalum (Latin)
  • Bromisoval (German)
  • Bromisoval (French)
  • Bromisoval (Spanish)

Generic Names

  • Bromisoval (OS: DCF)
  • Bromvalerylurea (OS: JAN)
  • Bromeval (IS)
  • Bromisovalum (IS)
  • Bromural (IS)
  • Bromurea (IS)
  • Bromvaletone (IS)
  • Brovalurea (IS)
  • BVU (IS)
  • Bromisovalum (PH: Ph. Helv. VI, Editio)
  • Bromvalerylurea (PH: JP XV)

Brand Names

  • Bromvalerylurea
    Sumio Yakuhin, Japan; Yoshida Seiyaku, Japan


  • Brovarin
    Nippon Shinyaku, Japan

International Drug Name Search

Glossary

DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday 8 May 2009

Ufarin




Ufarin may be available in the countries listed below.


Ingredient matches for Ufarin



Isoconazole

Isoconazole nitrate (a derivative of Isoconazole) is reported as an ingredient of Ufarin in the following countries:


  • Chile

International Drug Name Search

Monday 27 April 2009

Noginox




Noginox may be available in the countries listed below.


Ingredient matches for Noginox



Isoconazole

Isoconazole nitrate (a derivative of Isoconazole) is reported as an ingredient of Noginox in the following countries:


  • Colombia

  • Venezuela

International Drug Name Search

Friday 24 April 2009

Weiliufen




Weiliufen may be available in the countries listed below.


Ingredient matches for Weiliufen



Sulfasalazine

Sulfasalazine is reported as an ingredient of Weiliufen in the following countries:


  • China

International Drug Name Search

Wednesday 22 April 2009

Proleak




Proleak may be available in the countries listed below.


Ingredient matches for Proleak



Finasteride

Finasteride is reported as an ingredient of Proleak in the following countries:


  • Taiwan

International Drug Name Search

Wednesday 15 April 2009

Rheumafen




Rheumafen may be available in the countries listed below.


Ingredient matches for Rheumafen



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Rheumafen in the following countries:


  • Egypt

International Drug Name Search

Thursday 9 April 2009

Budesonida Aldo Union Nasal




Budesonida Aldo Union Nasal may be available in the countries listed below.


Ingredient matches for Budesonida Aldo Union Nasal



Budesonide

Budesonide is reported as an ingredient of Budesonida Aldo Union Nasal in the following countries:


  • Spain

International Drug Name Search

Wednesday 1 April 2009

Zolen




Zolen may be available in the countries listed below.


Ingredient matches for Zolen



Amisulpride

Amisulpride is reported as an ingredient of Zolen in the following countries:


  • Tunisia

Fluconazole

Fluconazole is reported as an ingredient of Zolen in the following countries:


  • Bangladesh

International Drug Name Search

Friday 27 March 2009

Diflu




Diflu may be available in the countries listed below.


Ingredient matches for Diflu



Fluconazole

Fluconazole is reported as an ingredient of Diflu in the following countries:


  • Bangladesh

  • Tunisia

International Drug Name Search

Tuesday 17 March 2009

Metronidazol Arcana




Metronidazol Arcana may be available in the countries listed below.


Ingredient matches for Metronidazol Arcana



Metronidazole

Metronidazole is reported as an ingredient of Metronidazol Arcana in the following countries:


  • Austria

International Drug Name Search

Sunday 15 March 2009

Bleomycin Hydrochloride




Bleomycin Hydrochloride may be available in the countries listed below.


Ingredient matches for Bleomycin Hydrochloride



Bleomycin

Bleomycin Hydrochloride (JAN) is known as Bleomycin in the US.

International Drug Name Search

Glossary

JANJapanese Accepted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday 14 March 2009

Citiflux




Citiflux may be available in the countries listed below.


Ingredient matches for Citiflux



Flunisolide

Flunisolide is reported as an ingredient of Citiflux in the following countries:


  • Italy

International Drug Name Search

Thursday 12 March 2009

Saphire




Saphire may be available in the countries listed below.


Ingredient matches for Saphire



Atorvastatin

Atorvastatin calcium (a derivative of Atorvastatin) is reported as an ingredient of Saphire in the following countries:


  • Turkey

International Drug Name Search

Wednesday 4 March 2009

Meliane




Meliane may be available in the countries listed below.


Ingredient matches for Meliane



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Meliane in the following countries:


  • Austria

  • Belgium

  • Colombia

  • Greece

  • Hungary

  • Luxembourg

  • Malta

  • Spain

  • Switzerland

  • Thailand

Gestodene

Gestodene is reported as an ingredient of Meliane in the following countries:


  • Austria

  • Belgium

  • Colombia

  • Greece

  • Hungary

  • Luxembourg

  • Malta

  • Spain

  • Switzerland

  • Thailand

International Drug Name Search

Monday 2 March 2009

Sucedal




Sucedal may be available in the countries listed below.


Ingredient matches for Sucedal



Zolpidem

Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Sucedal in the following countries:


  • Chile

International Drug Name Search

Sunday 1 March 2009

Micar




Micar may be available in the countries listed below.


Ingredient matches for Micar



Piroxicam

Piroxicam is reported as an ingredient of Micar in the following countries:


  • Argentina

International Drug Name Search

Saturday 28 February 2009

Zynovate




Zynovate may be available in the countries listed below.


Ingredient matches for Zynovate



Mometasone

Mometasone 17-(2-furoate) (a derivative of Mometasone) is reported as an ingredient of Zynovate in the following countries:


  • Oman

International Drug Name Search

Sunday 22 February 2009

Zurocid




Zurocid may be available in the countries listed below.


Ingredient matches for Zurocid



Simvastatin

Simvastatin is reported as an ingredient of Zurocid in the following countries:


  • Greece

International Drug Name Search

Wednesday 18 February 2009

Fefun




Fefun may be available in the countries listed below.


Ingredient matches for Fefun



Nystatin

Nystatin is reported as an ingredient of Fefun in the following countries:


  • Bangladesh

International Drug Name Search

Monday 16 February 2009

Nicholin H




Nicholin H may be available in the countries listed below.


Ingredient matches for Nicholin H



Citicoline

Citicoline is reported as an ingredient of Nicholin H in the following countries:


  • Japan

International Drug Name Search

Saturday 7 February 2009

Dysport




In the US, Dysport (abobotulinumtoxinA systemic) is a member of the drug class skeletal muscle relaxants and is used to treat Cervical Dystonia and Facial Wrinkles.

US matches:

  • Dysport

UK matches:

  • Dysport
  • Dysport 300 units (SPC)

Ingredient matches for Dysport



Botulinum A Toxin

Botulinum A Toxin is reported as an ingredient of Dysport in the following countries:


  • Australia

  • Austria

  • Belgium

  • Brazil

  • Colombia

  • Croatia (Hrvatska)

  • Czech Republic

  • Denmark

  • Estonia

  • Finland

  • France

  • Georgia

  • Germany

  • Greece

  • Hong Kong

  • Hungary

  • Iceland

  • Ireland

  • Israel

  • Italy

  • Latvia

  • Lithuania

  • Luxembourg

  • Malaysia

  • Malta

  • Netherlands

  • New Zealand

  • Norway

  • Oman

  • Poland

  • Portugal

  • Romania

  • Russian Federation

  • Serbia

  • Singapore

  • Slovakia

  • Slovenia

  • South Africa

  • Spain

  • Sweden

  • Switzerland

  • Taiwan

  • Tunisia

  • Turkey

  • United Kingdom

  • United States

  • Venezuela

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday 4 February 2009

Lisinopril Atid




Lisinopril Atid may be available in the countries listed below.


Ingredient matches for Lisinopril Atid



Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinopril Atid in the following countries:


  • Germany

International Drug Name Search

Thursday 22 January 2009

Gacida




Gacida may be available in the countries listed below.


Ingredient matches for Gacida



Aluminium Hydroxide

Aluminium Hydroxide is reported as an ingredient of Gacida in the following countries:


  • Thailand

Magnesium Trisilicate

Magnesium Trisilicate is reported as an ingredient of Gacida in the following countries:


  • Thailand

International Drug Name Search

Monday 19 January 2009

Levomycetinum




Levomycetinum may be available in the countries listed below.


Ingredient matches for Levomycetinum



Chloramphenicol

Chloramphenicol is reported as an ingredient of Levomycetinum in the following countries:


  • Georgia

International Drug Name Search

Sunday 18 January 2009

Simvastatina Grapa




Simvastatina Grapa may be available in the countries listed below.


Ingredient matches for Simvastatina Grapa



Simvastatin

Simvastatin is reported as an ingredient of Simvastatina Grapa in the following countries:


  • Spain

International Drug Name Search

Friday 16 January 2009

Ticlopidina Genfar




Ticlopidina Genfar may be available in the countries listed below.


Ingredient matches for Ticlopidina Genfar



Ticlopidine

Ticlopidine is reported as an ingredient of Ticlopidina Genfar in the following countries:


  • Colombia

  • Ecuador

International Drug Name Search